261/2347US=22 / Câncer
Lawrence TS, Haken RKT, Giaccia A. Principles of radiation oncology. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 307-36.

ASPECTOS BIOLOGICOS; RADIOTERAPIA; MECANISMOS E CONSEQUENCIAS DA RADIOTERAPIA; ABERRACOES CROMOSSOMICAS; EFEITOS DA RADIACAO; ESTRATEGIAS PARA OXIGENACAO DO TUMOR; CONDUTAS INVASIVAS; METODOS NAO-INVASIVOS; PLANOS DE TRATAMENTO; MODALIDADES DE TRATAMENTO; APLICACOES CLINICAS DA RADIOTERAPIA; TIPOS DE RADIACAO; TRATAMENTO INTENSO; FRACIONAMENTO; EFEITOS ADVERSOS; PRINCIPIOS DE COMBINACOES ANTICANCER

262/2347US=22 / Câncer
Devita Jr VT, Chu R. Principles of medical oncology. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 337-42.

PERSPECTIVAS HISTORICAS; PRINCIPIOS BASICOS; APLICACAO CLINICA DA QUIMIOTERAPIA; PRINCIPIOS DO CANCER; CELULA CINETICA; PRINCIPIOS GOVERNAMENTAIS; USO DA QUIMIOTERAPIA; DOSE INTENSA E QUIMIOTERAPIA COMBINADA

263/2347US=22 / Câncer
Devita Jr VT, Chu R. Biology of drug resistance. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 343-9.

P53; BCL-2

264/2347US=22 / Câncer
Devita Jr VT, Chu R. Assessment of clinical response. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 346-9.

QUIMIOTERAPIA NEO ADJUVANTE; QUIMIOTERAPIA ADJUVANTE

265/2347US=22 / Câncer
Restifo NP, Robbins PF, Rosenberg SA. Principles of immunotherapy. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 351-68.

CATEGORIAS DOS TUMORES; FATORES MULTIPLOS; TERAPIAS DO CANCER; TERAPIAS ESPECIFICAS; VACINAS PEPTIDICAS; VACINAS RECOMBINANTES; MONITORIZACAO IMUNOLOGICA

266/2347US=22 / Câncer
Earle CC, Schrag D. Principles of health services research. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 369-84.

NUMEROS METODOLOGICOS; CONDUTAS ASSISTENCIAIS; QUALIDADE NOS ESTUDOS ASSISTENCIAIS; ANALISE ECONOMICA; IDENTIFICACAO E AVALIACAO DE CUSTOS; MODELO ECONOMICO

267/2347US=22 / Câncer
Sznol M. Pharmacology of cancer chemotherapy: drug development. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 385-92.

DESENVOLVIMENTO DE MEDICAMENTOS; DESENVOLVIMENTO CLINICO; BASES PARA REGISTROS DE AGENTES ANTICANCER

268/2347US=22 / Câncer
Takimoto CH, Ng CM. Pharmacokinetics and pharmacodynamics. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 393-401.

ESTUDO FARMACOCINETICOS E FARMACODINAMICOS; CONCEITOS FARMACOCINETICOS; DISPONIBILIDADE; VOLUMES DE DISTRIBUICAO; CONCENTRACAO DE MEDICAMENTOS; CONCEITOS FARMACODINAMICOS; FARMACOCINETICAS E FARMACODINAMICAS EM MEDICAMENTOS ONCOLOGICOS

269/2347US=22 / Câncer
El-Khoueiry A, Lenz HJ. Pharmacogenomics. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 402-7.

FARMACOGENOMICAS; DEFINICOES; TERMOS; CONCEITOS; TOXICIDADE

270/2347US=22 / Câncer
Tew KD. Alkylating agents. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 407-19.

QUIMICA; CLASSIFICACAO; TOXICIDADES; USO TERAPEUTICO; NAUSEA; VOMITO; MEDULA OSSEA E TOXICIDADE; BEXIGA E RINS TOXICIDADE; CARCINOGENESIS; ALOPECIA; REACOES ALERGICAS; IMUNOSSUPRESSAO

271/2347US=22 / Câncer
Reed E. Cisplatin and its analogs. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 419-26.

CISPLATINO; FARMACOLOGIA CLINICA; CARBOPLATINA

272/2347US=22 / Câncer
Saif MW, Chu E. Antimetabolites. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 427-37.

MECANISMOS DE ACAO; MECANISMOS DE RESISTENCIA; FARMACOLOGIA CLINICA; TOXICIDADE

273/2347US=22 / Câncer
Rasheed ZA, Rubin EH. Topoisomerase - interacting agents. In: Devita Jr VT, Hellman S, Rosenberg AS. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 437-47.

AGENTES INTERATUANTES; MECANISMOS DE ACAO; MECANISMOS DE RESISTENCIA

274/2347US=22 / Câncer
Lee JJ, Harris LN. Antimicrotubule agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 447-56.

MICROTUBULOS; TAXOIDES

275/2347US=22 / Câncer
LoRusso PML, Ryan AJ, Boerner SA, Herbst RS. Small-molecule tyrosine kinase inhibitors. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 457-68.
276/2347US=22 / Câncer
Gore SD, Baylin SB, Herman JG. Histone deacetylase inhibitors and demethylating agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 477-85.

METILACAO E DNA

277/2347US=22 / Câncer
Molineaux CJ, Crews CM. Proteasome inhibitors. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 486-90.

BIOQUIMICA; PROLIFERACAO DE CELULAS

278/2347US=22 / Câncer
Copur MS, Rose M, Gettinger SN. Miscellaneous chemotherapeutic agents. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 490-5.

AGENTES QUIMIOTERAPICOS; BLEOMYCIN; PROCARBAZINE; THALIDOMIDE; LENALIDOMIDE

279/2347US=22 / Câncer
Sondak VK, Daud AI. Pharmacology of cancer biotherapeutics. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 497-505.

INTERFERONS; EFEITOS IMUNOLOGICOS DO INTERFERON; EFEITOS NAO IMUNOLOGICOS DO INTERFERON; TOXICIDADE CONSTITUCIONAL; TOXICIDADE HEMATOLOGICA; TOXICIDADE ORGANICA; TOXICIDADE NEUROPSIQUIATRICA; AUTOIMUNIDADE; INTERACAO MEDICAMENTOSA; DOSAGEM FARMACOLOGICA

280/2347US=22 / Câncer
Lotze MT. Interleukin therapy. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 506-22.

TERAPEUTICAS INTERLEUKINS

Primeira | Anterior | Próxima | Última